{"id":734821,"date":"2025-03-06T14:40:02","date_gmt":"2025-03-06T14:40:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=734821"},"modified":"2025-03-06T14:40:02","modified_gmt":"2025-03-06T14:40:02","slug":"recombinant-proteins-market-worth-32-billion-by-2028-marketsandmarkets","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/recombinant-proteins-market-worth-32-billion-by-2028-marketsandmarkets_734821.html","title":{"rendered":"Recombinant Proteins Market worth $3.2 billion by 2028 | MarketsandMarkets\u2122"},"content":{"rendered":"
\n
\"Recombinant<\/a><\/div>\n
\n
he Asia Pacific market is expected to register the highest CAGR of 7.8% during the forecast period.<\/div>\n<\/div>\n<\/div>\n
The global recombinant proteins market, valued at US$2.1B in 2022, is forecasted to grow at a 7.2% CAGR, reaching US$2.2B by 2023 and US$3.2B by 2028.<\/div>\n

Recombinant Proteins market<\/a> in terms of revenue was estimated to be worth $2.2 billion in 2023 and is poised to reach $3.2 billion by 2028, growing at a CAGR of 7.2% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. Market growth is largely driven by increasing prevalence of chronic diseases, increased demand for biologics and biosimilars due to patent expirations, escalating government support for research and development in life sciences and rising demand for personalized medicine.<\/p>\n

Based on product, the global recombinant proteins market is segmented into growth factors and chemokines, immune response proteins, structural proteins, membrane proteins, kinase proteins, regulatory proteins, recombinant metabolic enzymes, adhesion molecules and receptors, and other recombinant proteins. The growth factors and chemokines segment accounted for the largest share of the market in 2022. The segment dominant the market owing various factors such as diversified application of growth factors for various cellular processes such as cell growth, proliferation, differentiation and for the research in chemotaxis, neurobiology, wound healing, immunology, cancer, viral diseases, cell culture, and stem cell research.<\/p>\n

Request for FREE Sample Pages: https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=70095015<\/a><\/strong><\/p>\n

Based on application, the global recombinant proteins market is segmented into drug discovery & development, biopharmaceutical production, research, diagnostics and other applications. In 2022, the drug discovery & development segment accounted for the largest share of the recombinant proteins market. The largest share can be attributed to the growing importance of recombinant proteins in small molecule drug discovery programs and developing new compounds that impact the function of disease-associated proteins or their respective protein-protein interactions.<\/p>\n

Based on host cell, the global recombinant proteins market is segmented into mammalian systems, insect cells, & fungi, bacterial cells and other host cell. In 2022, the bacterial cells segment accounted for the largest share of the recombinant proteins market. The largest share is due to factors such as well-characterized genetics, ease of manipulation, and cost-effectiveness compared to other systems.<\/p>\n

Based on end user, the global recombinant proteins market is segmented into, pharmaceutical & biopharmaceuticals companies, biotechnology companies, academic & research institutes, contract research organizations (CROs) and other end users. In 2022, pharmaceutical & biopharmaceuticals companies segment accounted for the largest share of the market. The key factor of driving the growth of this market segment can be attributed to the utilization of recombinant proteins in the identification of prognostic, predictive, and diagnostic markers and quantifying biomarkers during drug discovery & development.<\/p>\n

Based on the region, the global recombinant proteins market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. In 2022, North America accounted for the largest share in the recombinant proteins market, Europe is the second largest region in 2022. The dominance in the market can be attributed to to the rising acceptance of personalized medicine, increasing academic & government investments in diagnostic research and active government support. The Asia Pacific market is expected to register the highest CAGR of 7.8% during the forecast period. In 2022, the growth of the market is driven by the increasing government intitaives for life sciences research, rising investment for academic collaboration and rising prevalence of chronic diseases in this region.<\/p>\n

Buy a Recombinant Proteins Industry Report (406 Pages PDF with Insightful Charts, Tables, and Figures): https:\/\/www.marketsandmarkets.com\/Purchase\/purchase_reportNew.asp?id=70095015<\/a><\/strong><\/p>\n

Recombinant Proteins market major players covered in the report, such as:<\/strong><\/p>\n